Concepedia

G. Frangin

GF

Statistics

Publications

7

Citations

1.8K

H-Index

7

Active since

1993

Affiliations

Sanofi (France)(Current)

St George's Hospital

Amsterdam UMC Location University of Amsterdam

St George's, University of London

University of Pavia

G. Frangin is an author at Sanofi (France) specializing in cardiovascular disease, cardiology, and medicine.

Top concepts

Publications per year

1993–2005

7

Publications

7

Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT

D G Julian, AJ Camm, G. Frangin et al. · The Lancet · 1997 · 1.1K citations · Full text

, , +7

Amiodarone Interaction With β-Blockers

Florent Boutitie, Jean‐Pierre Boissel, Stuart J. Connolly et al. · Circulation · 1999 · 251 citations · Full text

The Irbesartan in Heart Failure With Preserved Systolic Function (I-PRESERVE) Trial: Rationale and Design

Peter E. Carson, Barry M. Massie, Robert S. McKelvie et al. · Journal of Cardiac Failure · 2005 · 139 citations

, , +7

The European Myocardial Infarct Amiodarone Trial (EMIAT)

A. John Camm, Desmond G. Julian, G. Janse et al. · The American Journal of Cardiology · 1993 · 130 citations

, , +6

Depressed heart rate variability identifies postinfarction patients who might benefit from prophylactic treatment with amiodarone

Marek Malik, A. John Camm, Michiel J. Janse et al. · Journal of the American College of Cardiology · 2000 · 112 citations

, , +9

1–5 of 7